Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion

Matching molecularly targeted therapies with cancer subtype-specific gene mutations is revolutionizing oncology care. However, for rare cancers this approach is problematic due to the often poor understanding of the disease's natural history and phenotypic heterogeneity, making treatment of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekulic, Aleksandar, Liang, Winnie S, Tembe, Waibhav, Izatt, Tyler, Kruglyak, Semyon, Kiefer, Jeffrey A, Cuyugan, Lori, Zismann, Victoria, Legendre, Christophe, Pittelkow, Mark R, Gohmann, John J, De Castro, Fernando R, Trent, Jeffrey, Carpten, John, Craig, David W, McDaniel, Timothy K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367085/
https://www.ncbi.nlm.nih.gov/pubmed/25802883
http://dx.doi.org/10.1002/mgg3.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367085/
https://www.ncbi.nlm.nih.gov/pubmed/25802883
http://dx.doi.org/10.1002/mgg3.121

Ejemplares similares